Abstract
Anna Piai, Bianca Bordigoni, L. Antunovic, E. Busnardo, Carla Canevari, F. Fallanca, P. Magnani, P. Mapelli, Arturo Chiti, Antonella Del Vecchio
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
pubmed
Confidence 98%
europepmc
Confidence 96%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
European guidelines update on PSMA PET / CT for prostate cancer staging — snap back to reality
10.1007/s00259-023-06287-0 · 2023
The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study
10.2967/jnumed.117.197160 · 2018
Impact of 68 Ga-PSMA PET on the management of patients with prostate cancer: A systematic review and meta-analysis
10.1016/j.eururo.2018.03.030 · 2018
Guideline for PET / CT imaging of neuroendocrine neoplasms with 68 Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18 F-DOPA
10.1007/s00259-017-3728-y · 2017
A review on personalized pediatric dosimetry applications using advanced computational tools
10.1109/trpms.2018.2876562 · 2018
Coefficient of variation and texture analysis of 18F-FDG PET / CT images for the prediction of outcome in patients with multiple myeloma
10.1007/s00277-024-05905-7 · 2024
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN)
10.1007/s40336-019-00328-1 · 2019
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms
10.3390/diagnostics11020192 · 2021
Clinical applications of Gallium-68
10.1016/j.apradiso.2013.01.039 · 2013
A review of digital PET-CT technology: Comparing performance parameters in SiPM integrated digital PET-CT systems
10.1016/j.radi.2023.10.004 · 2024
Image quality and activity optimization in oncologic 18F-FDG PET using the digital biograph vision PET/CT system
10.2967/jnumed.119.234351 · 2020
EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data
10.1007/s00259-022-05919-1 · 2022
NEMA NU 2-2018 evaluation and image quality optimization of a new generation digital 32-cm axial field-of-view Omni Legend PET-CT using a genetic evolutionary algorithm
10.1088/2057-1976/ad286c · 2024
An extended bore length solid ‑ state digital ‑ BGO PET / CT system: design, preliminary experience, and performance characteristics
10.1007/s00259-023-06514-8 · 2024
Performance characteristics of a new-generation digital bismuth germanium oxide PET/CT system, Omni legend 32, according to NEMA NU 2-2018 standards
10.2967/jnumed.123.266140 · 2023
Effects of a deep learning‑based image quality enhancement method on a digital‑BGO PET/CT system for 18F‑FDG whole‑body examination
10.1186/s40658-025-00742-7 · 2025
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems
10.1007/s00259-017-3853-7 · 2018
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
10.1007/s00259-014-2961-x · 2015
[18F]FDG PET/CT: EANM procedure guidelines for tumour imaging: version 3.0
10.1016/j.eanmj.2025.100006 · 2025
Standardisation of conventional and advanced iterative reconstruction methods for Gallium-68 multi-centre PET-CT trials
10.1186/s40658-021-00400-8 · 2021
[18 F]FDG administered activity reduction capabilities of a 32-cm axial field-of-view solid-state digital bismuth germanium oxide PET/CT system while maintaining EARL compliance
2025
Unresolved referenced work
Kept as external metadata until matched
Quantitative oncology molecular analysis suite: ACCURATE
2018
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
SNMMI procedure standard/EANM practice guideline for SSTR PET: Imaging neuroendocrine Tumors
10.2967/jnumed.122.264860 · 2023
MotionFree Device-less digital respiratory gating technique, seamlessly integrated in PET imaging routine
2019
10.37206/193
10.37206/193
Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom
10.1002/mp.12623 · 2017
Multicentre quantitative 68 Ga PET/CT performance harmonisation
10.1186/s40658-019-0253-z · 2019
Beyond 18F-FDG: characterization of PET/CT and PET/MR scanners for a comprehensive set of positron emitters of growing application—18F, 11C, 89Zr, 124I, 68Ga, and 90Y
10.2967/jnumed.115.156711 · 2015
SUV harmonization in the era of advanced PET: a necessary recalibration
10.1016/j.eanmj.2026.100016 · 2026
Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT
10.1007/s12149-017-1192-1 · 2017
Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET/CT system
10.2967/jnumed.115.159301 · 2015
Changes of [18F]FDG-PET/CT quantitative parameters in tumor lesions by the Bayesian penalized-likelihood PET reconstruction algorithm and its influencing factors
10.1186/s12880-021-00664-7 · 2021
Improving image reconstruction to quantify dynamic whole-body PET/CT: Q.Clear versus OSEM
10.1186/s40658-025-00736-5 · 2025
Quantitative implications of the updated EARL 2019 PET – CT performance standards
10.1186/s40658-019-0257-8 · 2019
Variability in PET image quality and quantification measured with a permanently filled 68 Ge ‑ phantom : A multi‑center study
10.1186/s40658-023-00551-w · 2023
Variability in PET image quality and quantification measured with a permanently filled 68 Ge ‑ phantom : A multi‑center study
10.1186/s40658-023-00551-w · doi-reference
Quantitative implications of the updated EARL 2019 PET – CT performance standards
10.1186/s40658-019-0257-8 · doi-reference
Improving image reconstruction to quantify dynamic whole-body PET/CT: Q.Clear versus OSEM
10.1186/s40658-025-00736-5 · doi-reference
Changes of [18F]FDG-PET/CT quantitative parameters in tumor lesions by the Bayesian penalized-likelihood PET reconstruction algorithm and its influencing factors
10.1186/s12880-021-00664-7 · doi-reference
Phantom and clinical evaluation of the Bayesian penalized likelihood reconstruction algorithm Q.Clear on an LYSO PET/CT system
10.2967/jnumed.115.159301 · doi-reference
Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT
10.1007/s12149-017-1192-1 · doi-reference
SUV harmonization in the era of advanced PET: a necessary recalibration
10.1016/j.eanmj.2026.100016 · doi-reference
Beyond 18F-FDG: characterization of PET/CT and PET/MR scanners for a comprehensive set of positron emitters of growing application—18F, 11C, 89Zr, 124I, 68Ga, and 90Y
10.2967/jnumed.115.156711 · doi-reference
Multicentre quantitative 68 Ga PET/CT performance harmonisation
10.1186/s40658-019-0253-z · doi-reference
Impact of PET/CT system, reconstruction protocol, data analysis method, and repositioning on PET/CT precision: An experimental evaluation using an oncology and brain phantom
10.1002/mp.12623 · doi-reference
10.37206/193
10.37206/193 · doi-reference
SNMMI procedure standard/EANM practice guideline for SSTR PET: Imaging neuroendocrine Tumors
10.2967/jnumed.122.264860 · doi-reference
Standardisation of conventional and advanced iterative reconstruction methods for Gallium-68 multi-centre PET-CT trials
10.1186/s40658-021-00400-8 · doi-reference
[18F]FDG PET/CT: EANM procedure guidelines for tumour imaging: version 3.0
10.1016/j.eanmj.2025.100006 · doi-reference
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
10.1007/s00259-014-2961-x · doi-reference
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems
10.1007/s00259-017-3853-7 · doi-reference
Effects of a deep learning‑based image quality enhancement method on a digital‑BGO PET/CT system for 18F‑FDG whole‑body examination
10.1186/s40658-025-00742-7 · doi-reference
Performance characteristics of a new-generation digital bismuth germanium oxide PET/CT system, Omni legend 32, according to NEMA NU 2-2018 standards
10.2967/jnumed.123.266140 · doi-reference
An extended bore length solid ‑ state digital ‑ BGO PET / CT system: design, preliminary experience, and performance characteristics
10.1007/s00259-023-06514-8 · doi-reference
NEMA NU 2-2018 evaluation and image quality optimization of a new generation digital 32-cm axial field-of-view Omni Legend PET-CT using a genetic evolutionary algorithm
10.1088/2057-1976/ad286c · doi-reference
EARL compliance and imaging optimisation on the Biograph Vision Quadra PET/CT using phantom and clinical data
10.1007/s00259-022-05919-1 · doi-reference
Image quality and activity optimization in oncologic 18F-FDG PET using the digital biograph vision PET/CT system
10.2967/jnumed.119.234351 · doi-reference
A review of digital PET-CT technology: Comparing performance parameters in SiPM integrated digital PET-CT systems
10.1016/j.radi.2023.10.004 · doi-reference
Clinical applications of Gallium-68
10.1016/j.apradiso.2013.01.039 · doi-reference
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms
10.3390/diagnostics11020192 · doi-reference
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN)
10.1007/s40336-019-00328-1 · doi-reference
Coefficient of variation and texture analysis of 18F-FDG PET / CT images for the prediction of outcome in patients with multiple myeloma
10.1007/s00277-024-05905-7 · doi-reference
A review on personalized pediatric dosimetry applications using advanced computational tools
10.1109/trpms.2018.2876562 · doi-reference
Guideline for PET / CT imaging of neuroendocrine neoplasms with 68 Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18 F-DOPA
10.1007/s00259-017-3728-y · doi-reference
Impact of 68 Ga-PSMA PET on the management of patients with prostate cancer: A systematic review and meta-analysis
10.1016/j.eururo.2018.03.030 · doi-reference
The impact of 68Ga-PSMA PET/CT on management intent in prostate cancer: results of an Australian prospective multicenter study
10.2967/jnumed.117.197160 · doi-reference
European guidelines update on PSMA PET / CT for prostate cancer staging — snap back to reality
10.1007/s00259-023-06287-0 · doi-reference